{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:42:49Z","timestamp":1785166969413,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jdiacomp.2021.107848","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T09:31:21Z","timestamp":1610184681000},"page":"107848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Urinary adiponectin excretion is an early predictive marker of the decline of the renal function in patients with diabetes mellitus"],"prefix":"10.1016","volume":"35","author":[{"given":"Masashi","family":"Ishizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Akehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Hashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehide","family":"Matsuhisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2021.107848_bb0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/dc18-1320","article-title":"Nonproteinuric versus proteinuric phenotypes in diabetic kidney disease: a propensity score-matched analysis of a nationwide, biopsy-based cohort study","volume":"42","author":"Yamanouchi","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11684-017-0542-7","article-title":"Normoalbuminuric diabetic kidney disease","volume":"11","author":"Chen","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0025","article-title":"Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15)","volume":"24","author":"Yokoyama","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s10157-017-1485-7","article-title":"Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy","volume":"22","author":"Furuichi","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2215\/CJN.04650417","article-title":"Diabetic kidney disease","volume":"13","author":"Tong","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0040","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0045","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2215\/CJN.11111016","article-title":"Diagnosis and management of type 2 diabetic kidney disease","volume":"12","author":"Doshi","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jfma.2018.02.007","article-title":"Update of pathophysiology and management of diabetic kidney disease","volume":"117","author":"Lin","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0055","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ki.2012.443","article-title":"Change in the estimated glomerular filtration rate over time and risk of all-cause mortality","volume":"83","author":"Turin","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0060","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2015060687","article-title":"Past decline versus current eGFR and subsequent ESRD risk","volume":"27","author":"Kovesdy","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0065","doi-asserted-by":"crossref","unstructured":"Chapter 2: Definition, identification, and prediction of CKD progression. Kidney Int Suppl (2011). 2013;3:63\u201372. doi:https:\/\/doi.org\/10.1038\/kisup.2012.65.","DOI":"10.1038\/kisup.2012.65"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jdiacomp.2018.07.003","article-title":"Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes","volume":"32","author":"Barzilay","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0075","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00125-018-4567-5","article-title":"Biomarkers of diabetic kidney disease","volume":"61","author":"Colhoun","year":"2018","journal-title":"Diabetologia."},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0080","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ki.2015.199","article-title":"Biomarkers of rapid chronic kidney disease progression in type 2 diabetes","volume":"88","author":"Looker","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2337\/db18-0838","article-title":"The familiality of rapid renal decline in diabetes","volume":"68","author":"Frodsham","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0090","first-page":"1645","article-title":"Adiponectin regulates albuminuria and podocyte function in mice","volume":"118","author":"Sharma","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0095","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.2337\/db09-0204","article-title":"Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes","volume":"58","author":"von Eynatten","year":"2009","journal-title":"Diabetes."},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1507\/endocrj.K06-016","article-title":"Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy","volume":"53","author":"Hujita","year":"2006","journal-title":"Endocr J"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000661","article-title":"Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy","volume":"7","author":"Yamakado","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2004.02.032","article-title":"Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy","volume":"316","author":"Koshimura","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0115","first-page":"883","article-title":"Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy","volume":"38","author":"Panduru","year":"2015"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0120","first-page":"479","article-title":"Urinary excretion of high molecular weight adiponectin is an independent predictor of decline of renal function in type 2 diabetes","volume":"51","author":"Kopf","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1387-2656(08)70058-9","article-title":"Ultrasensitive enzyme immunoassay","volume":"1","author":"Hashida","year":"1995","journal-title":"Biotechnol Annu Rev"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jim.2018.05.010","article-title":"The immune complex transfer enzyme immunoassay: mechanism of improved sensitivity compared with conventional sandwich enzyme immunoassay","volume":"459","author":"Watanabe","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0004563217748681","article-title":"A study of high-, middle- and low-molecular weight adiponectin in urine as a surrogate marker for early diabetic nephropathy using ultrasensitive immune complex transfer enzyme immunoassay","volume":"55","author":"Yamamoto","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1053\/j.ajkd.2007.09.004","article-title":"Modification of the Modification of Diet in Renal Disease (MDRD) study equation for Japan","volume":"50","author":"Imai","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0145","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/diabetes.49.9.1399","article-title":"Perspectives in diabetes the need for early predictors of diabetic nephropathy risk is albumin excretion rate sufficient?","volume":"49","author":"Caramori","year":"2000","journal-title":"Diabetes."},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0150","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/diacare.24.9.1560","article-title":"Does microalbuminuria predict diabetic nephropathy?","volume":"24","author":"Bahman","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2015.03.017","article-title":"L-FABP: a novel biomarker of kidney disease","volume":"445","author":"Xu","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0160","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1038\/s41598-020-72494-6","article-title":"Development of fully automated and ultrasensitive assays for urinary adiponectin and their application as novel biomarkers for diabetic kidney disease","volume":"10","author":"Watanabe","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0165","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00125-016-3937-0","article-title":"Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria","volume":"59","author":"von Scholten","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0170","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3390\/ijms20071782","article-title":"Mechanisms of adiponectin action: implication of adiponectin receptor agonism in diabetic kidney disease","volume":"20","author":"Kim","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0175","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1038\/s41598-020-62465-2","article-title":"High serum adiponectin as a biomarker of renal dysfunction: results from the KNOW-CKD study","volume":"10","author":"Song","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2021.107848_bb0180","doi-asserted-by":"crossref","DOI":"10.5301\/jn.5000269","article-title":"Adiponectin is expressed and secreted by renal tubular epithelial cells","volume":"26","author":"Perri","year":"2013","journal-title":"J Nephrol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:13:56Z","timestamp":1761005636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872721000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1056872721000027"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.107848","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary adiponectin excretion is an early predictive marker of the decline of the renal function in patients with diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.107848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107848"}}